Thalassemia News and Research

Latest Thalassemia News and Research

Celgene to share new and updated data around novel hematological therapies

Celgene Corporation today announced that data from a broad range of early and late stage studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 23rd European Hematology Association annual meeting in Stockholm, Sweden, from June 14-17, 2018.

22 May 2018

Study shows gene variations associated with malaria risk

Many people of African heritage are protected against malaria by inheriting a particular version of a gene, a large-scale study has shown.

25 Apr 2018

Smart Cells launches social campaign to support Rare Disease Day 2018

There are more than 6000 known rare diseases and over 30 million people living daily with them. 28th February marks Rare Disease Day 2018, a date that highlights awareness around these conditions and the need for more research into them.

From Smart Cells International Ltd 23 Feb 2018

Company-sponsored CRISPR clinical studies to begin in 2018

This year could be a defining one for CRISPR, the gene editing technique, which has been hailed as an important breakthrough in laboratory research.

10 Jan 2018

Sangamo and Pfizer partner for development of new zinc finger protein gene therapy to treat ALS

Sangamo Therapeutics, Inc. and Pfizer Inc. today announced a collaboration for the development of a potential gene therapy using zinc finger protein transcription factors (ZFP-TFs) to treat amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) linked to mutations of the C9ORF72 gene.

8 Jan 2018

“Chemical surgery” on embryos to free them of a gene causing thalassemia

A team of Chinese researchers have for the first time “mended” defective embryos using chemical surgery to free them of a faulty gene that leads to beta thalassemia. Until now this defect was found to be incorrigible caused due to a single misspelling in the DNA code. Beta thalassemia is a dreaded blood disorder wherein the child is unable to make healthy blood needing blood transfusions on a regular basis. The study was published this week in the journal Protein and Cell.

2 Oct 2017

Metabolism can impact host's susceptibility to develop malaria

Researchers from Instituto de Medicina Molecular Lisboa have found that the host's susceptibility to develop malaria depends on his or her metabolic state, which can be easily manipulated through external stimuli such as dietary patterns.

25 Sep 2017

Leeds Teaching Hospitals to introduce private stem cell collection and storage option for patients

The Leeds Teaching Hospitals NHS Trust is continually striving to provide high quality, patient centred care to each and every patient. Smart Cells International, in association with the trust, will be introducing the option for patients to privately store stem cells from the umbilical cord across St James’s University Hospital, Leeds General Infirmary and Wharfedale Hospital.

14 Sep 2017

Study provides insight into development of red blood cells

Every cell in the body, whether skin or muscle or brain, starts out as a generic cell that acquires its unique characteristics after undergoing a process of specialization. Nowhere is this process more dramatic than it is in red blood cells.

18 Aug 2017

Malaria already widespread on Sardinia in the Roman period, research shows

Malaria was already widespread on Sardinia by the Roman period, long before the Middle Ages, as indicated by research at the Institute of Evolutionary Medicine of the University of Zurich with the help of a Roman who died 2,000 years ago.

27 Jul 2017

US scientists make advances in modifying human embryos

American Scientists have managed to edit and improve the DNA of human embryos in an effort to correct the gene defects that cause inherited diseases.

27 Jul 2017

Infographic displays facts and information about stem cells, cord blood

Over 40,000 people have successfully stored stem cells with Smart Cells, however the industry is still relatively unknown and often subject to misinformation. In a bid to increase awareness and understanding of stem cell collection at birth, Smart Cells have created an informative infographic.

17 Jul 2017

Sangamo Therapeutics and Pfizer team up for development of Hemophilia A gene therapy

Sangamo Therapeutics, Inc. and Pfizer Inc. today announced an exclusive, global collaboration and license agreement for the development and commercialization of gene therapy programs for Hemophilia A, including SB-525, one of Sangamo's four lead product candidates, which Sangamo expects will enter the clinic this quarter.

11 May 2017

Thalassemia News and Research

Latest Thalassemia News and Research

Celgene to share new and updated data around novel hematological therapies

Study shows gene variations associated with malaria risk

Smart Cells launches social campaign to support Rare Disease Day 2018

Company-sponsored CRISPR clinical studies to begin in 2018

Sangamo and Pfizer partner for development of new zinc finger protein gene therapy to treat ALS

“Chemical surgery” on embryos to free them of a gene causing thalassemia

Metabolism can impact host's susceptibility to develop malaria

Leeds Teaching Hospitals to introduce private stem cell collection and storage option for patients

Study provides insight into development of red blood cells

Malaria already widespread on Sardinia in the Roman period, research shows

US scientists make advances in modifying human embryos

Infographic displays facts and information about stem cells, cord blood

Sangamo Therapeutics and Pfizer team up for development of Hemophilia A gene therapy

Researchers develop robust technique for efficient manufacture of red blood cells

Innovative gene therapy allows complete remission of clinical signs of sickle cell disease

Brazilian researchers propose new way for treating thalassemia major

Epigem challenges Durham University students to develop diagnostic devices for rare anaemic conditions

Yale researchers use new gene editing technique to correct mutations that cause thalassemia

Genome engineering-based methods pave way for new treatment of patients with sickle cell disease

Scientists find new way to use CRISPR gene editing to help fix sickle cell disease

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Thalassemia News and Research

Latest Thalassemia News and Research

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Newsletters you may be interested in